Does Lexaria Bioscience Corp (LEXX) Have What it Takes to be in Your Portfolio Wednesday?

Lexaria Bioscience Corp (LEXX) is around the top of the Biotechnology industry according to InvestorsObserver. LEXX received an overall rating of 75, which means that it scores higher than 75 percent of all stocks. Lexaria Bioscience Corp also achieved a score of 89 in the Biotechnology industry, putting it above 89 percent of Biotechnology stocks. Biotechnology is ranked 20 out of the 148 industries.

LEXX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on LEXX!

See Full LEXX Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Lexaria Bioscience Corp Stock Today?

Lexaria Bioscience Corp (LEXX) stock is down -0.79% while the S&P 500 has risen 0.35% as of 12:32 PM on Wednesday, Mar 27. LEXX is down -$0.03 from the previous closing price of $3.79 on volume of 187,455 shares. Over the past year the S&P 500 is up 31.49% while LEXX has risen 51.61%. LEXX lost -$0.84 per share the over the last 12 months. Click Here to get the full Stock Report for Lexaria Bioscience Corp stock.